BRIEF-Soligenix says SGX301 receives PIM designation in the UK
* Soligenix Inc - SGX301 (synthetic hypericin) has been granted Promising Innovative Medicine (PIM) designation in United Kingdom [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: designation, SGX301, Kingdom, in United, (PIM), Medicine, Innovative, Promising, been granted, hypericin), (synthetic, Soligenix, receives, BRIEF-Soligenix
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/YxTb6lPtCYo/idUSFWN1FN0IC